期刊文献+

度洛西汀与帕罗西汀治疗广泛性焦虑的对照分析 被引量:2

下载PDF
导出
摘要 目的评价度洛西汀治疗广泛性焦虑的临床疗效及安全性。方法对84例广泛性焦虑患者随机分为度洛西汀组和帕罗西汀组各42例,治疗8周,采用汉密尔顿焦虑量表(HAMA)和临床疗效总评量表、病情严重程度(CGI-SI)评定临床疗效,副反应量表(TESS)评定药物不良反应。结果经8周治疗,度洛西汀组和帕罗西汀组有效率分别为85.71%和83.33%,显效率分别为66.67%和64.29%,2组比较差异无统计学意义(P>0.05),2组不良反应发生率比较差异无统计学意义(P>0.05)。结论度洛西汀治疗广泛性焦虑安全有效,不良反应轻微,值得临床推广。
机构地区 天津市安定医院
出处 《中国实用神经疾病杂志》 2014年第20期45-46,共2页 Chinese Journal of Practical Nervous Diseases
  • 相关文献

参考文献16

  • 1马洪涛,王金明,许家泉.度洛西汀治疗广泛性焦虑症的对照研究[J].精神医学杂志,2009,22(5):389-390. 被引量:8
  • 2Graeff FG,Viana MB, Mora PO. Dual role of 5-HT in defense and anxiety[J]. Neurosci Biobehav Rev, 1997,21 = 791-799.
  • 3Wrase J, Reimold M, Puis I, et al. Serotonergic dysfunction: brain imaging and behavioral correlates[J]. Cogn Affect Behav Neurosci,2006,6=53 61.
  • 4Morilak DA,Barrera G,Echevarria DJ,et al. Role of brain nor- epinephrine in the behavioral response to stress[J]. Prog Neu- ropsychopharmacol Biol Psychiatry, 2005,29 = 1 214 1 224.
  • 5Wong DT, Bymaster FP, Mayle DA, et al. LY248686, a new in- hibitor of serotonin and norepinephrine uptake [J]. Neuropsy- chopharmacology, 1993,8 : 23-33.
  • 6Baldwin DS, Polkinghorn C. Evidence-based pharmacotherapy of generalized anxiety disorder[J]. Int J Neuropsychopharma- col, 2005,8 : 293-302.
  • 7Iny LI, Pecknold J, Suranyi-Cadotte BE, et aL Studies of a neurochemical link between depression, anxiety, and stress from [3Himipramine and [3Hparoxetine binding on human platelets[J]. Biol Psychiatry, 1994,36 : 281 291.
  • 8Fava M, Martinez JM, Greist J, et al. The efficacy and tolera bility of duloxetine in the treatment of anxious versus nonanx ious depression:a post-hoc analysis of an open-label oupatiem study[J]. Ann Clin Psychiatry,2007,19:187-195.
  • 9Rynn MA,Brawman-Mintzer O. Generalized anxiety disorder: acute and chronic treatment [J]. CNS Spectr, 2004, 9:716 723.
  • 10Pollack MH. Optimizing pharmaeotherapy of generalized anxi ety disorder to achieve remission[J]. J Clin Psychiatry, 2001, 62:20-25.

二级参考文献361

  • 1四川美康医药软件研究开发有限公司.MIC用药手册[M].第一版.香港:中国医学出版社,2006,480-481.
  • 2Michael J, Detkea MD, Yili L, et al. Duloxetine 60mg once daily dosing versus placebo in the acute treatment of major depression[J]. Journal of Psychiatric Research,2003,40:383.
  • 3Michael J, Detkea MD. Duloxetine, 60mg daily, for major depressive disorder: A randomized double-blind placebo controlled trial[ J]. J Clin Psychiatry,2003,63:308.
  • 4David L, Dunner A, Deborahn, et al. Is treatment associated hypomania rare with duloxetine: Secondary analysis of controlled trials in non-bipolar depression [ J ]. Journal of Affeetive Disorders ,2005,87 : 115.
  • 5Connor KM, Pavidsm JRT. The neurobiology ofgeneralized anxiety disorder[ J ]. Buil Psychiatry ,2008,44 : 1284 - 1287.
  • 6Michael J, Detke, Curtis G Wihse, et al. Duloxetine in the acute and long-term treatment of major depressive disorder:a placebo and paroxetine-controlled trial [ J ]. Eur Neuropsychopharmacol, 2004,14 ( 6 ) : 457.
  • 7Chalon SA, Granier LA, Vandenhende FR, et al. Duloxetine increases serotonin and norepinephrine availability in healthy subjects : a double lind, controlled study [ J ]. Neuropsychopharmacology ,2003,28 (9) : 1685.
  • 8Goldstein AJ,de Beurs E,Chambless DL,Wilson KA(2000)EMDR for panic disorder with agoraphobia:comparison with waiting list and credible attention-placebo control conditions.J Consuit Clin Psychol 68:947-956.
  • 9Davidson JR, DuPont RL, Hedges D, Haskins JT (1999) Efficacy,safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalised anxiety disorder. J Clin Plychiatry 60: 528-535.
  • 10Davidson J, Pearlstein T, Londborg P, Brady KT, Rothbaum 8, Bell J,Maddock R, Hegel MT, Farfel G (2001a) Effcacy of sertraline in preventing relapse of posttrauma(ic stress disorder:results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry 158:1974-1981.

共引文献35

同被引文献29

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部